Organisation paid for research Program year 2025 Source: CMS Open Payments

Tasok LLC

Neither a doctor nor a teaching hospital

Research payments

$2,144,653

121 payments

Through program year 2025, Tasok LLC is reported as receiving $2,144,653 in research payments, across 121 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$99,614	8
2024	Research	$90,173	8
2023	Research	$171,014	13
2022	Research	$293,497	17
2021	Research	$716,866	32
2020	Research	$553,593	27
2019	Research	$219,897	16

Breakdown

Who paid Research payments · program years 2019–2025

Genentech, Inc. $2,131,940 114 payments
Allergan Inc. $11,940 5 payments
Bayer HealthCare Pharmaceuticals Inc. $774 2 payments

Studies the money was for Research payments · program years 2019–2025

Study of the Port Delivery System With Ranibizumab in Patients With Diabetic MacUlar Edema $854,922 35 payments
Va2 Phiii Rhine $748,888 26 payments
Faricimab Dme Long Term Extension Rhone X $296,737 21 payments
A Phase III Multicenter Observation Comparator Study of the Efficacy Safety and Pharmacokinetics $167,713 20 payments
Port Delivery System for Ranibizumab $50,781 10 payments
Belvedere $12,900 2 payments
Phase 2 - Evaluation of Abicipar Pegol in Patients With Namd 1771-201-008 $8,300 3 payments
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-Related MacUlar Degeneration $3,640 2 payments
BAY865321 HD 8mg AMD - Ph 3 $774 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.